Soluble form of GMP-140
US5767241A · kind A · utility
14Cited by
3References
5Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jul 8, 1994 |
| Grant date | Jun 16, 1998 |
| Priority date | — |
| Expiry date | Jul 8, 2014 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention is directed to a purified soluble form of human granule membrane protein 140 (GMP-140) which lacks an amino acid sequence comprising a transmembrane domain and which is effective in inhibiting leukocyte adherence mediated by granule membrane protein 140. Nucleic acid encoding the soluble form of GMP-140 is disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.